Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Cercek

Showing results (41-50 of 214) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|March 24, 2021
The Spectrum of Benefit from Checkpoint Blockade in Hypermutated TumorsBenoit Rousseau, Michael B Foote, Steven B Maron, et al.
Cell Reports. Medicine|March 28, 2025
Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translationNicole Aguirre, Darren R Veach, Andrea Cercek, et al.
Advances in Radiation Oncology|April 24, 2020
Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer CenterPaul B Romesser, Abraham J Wu, Andrea Cercek, et al.
JMIR Public Health and Surveillance|November 7, 2023
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control StudyIrit Ben-Aharon, Ran Rotem, Cheli Melzer-Cohen, et al.
JCO Precision Oncology|February 27, 2023
Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial FloxuridineMelissa Lumish, Jennifer Thackray, Richard Kinh Gian Do, et al.
Journal of Oncology Practice|April 14, 2016
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/minAndrea Cercek, Vivian Park, Rona Yaeger, et al.
Clinical Colorectal Cancer|March 19, 2025
A Phase Two, Single-Arm, Open-Label Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)Andrea Cercek, Jean-Baptiste Bachet, Jaume Capdevila, et al.
Cancer Cell|November 1, 2024
Fertility outcomes post immune checkpoint inhibitor exposureEmily C Harrold, Martinique Ogle, Erin O'Brien, et al.
Clinical Colorectal Cancer|February 7, 2022
Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin HypersensitivitySalvador Alonso Martinez, Neil H Segal, Andrea Cercek, et al.
Current Treatment Options in Oncology|June 14, 2017
A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal MetastasesAndrea Cercek, Vyacheslav Gendel, Salma Jabbour, et al.
Pageof 22

Showing results (41-50 of 214) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|March 24, 2021
The Spectrum of Benefit from Checkpoint Blockade in Hypermutated TumorsBenoit Rousseau, Michael B Foote, Steven B Maron, et al.
Cell Reports. Medicine|March 28, 2025
Radioimmunotherapy for peritoneal carcinomatosis: Preclinical proof of concept to clinical translationNicole Aguirre, Darren R Veach, Andrea Cercek, et al.
Advances in Radiation Oncology|April 24, 2020
Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer CenterPaul B Romesser, Abraham J Wu, Andrea Cercek, et al.
JMIR Public Health and Surveillance|November 7, 2023
Pharmaceutical Agents as Potential Drivers in the Development of Early-Onset Colorectal Cancer: Case-Control StudyIrit Ben-Aharon, Ran Rotem, Cheli Melzer-Cohen, et al.
JCO Precision Oncology|February 27, 2023
Precision Management of a Patient With Dihydropyrimidine Dehydrogenase Deficiency and Liver-Predominant Metastatic Rectal Cancer Using Hepatic Arterial FloxuridineMelissa Lumish, Jennifer Thackray, Richard Kinh Gian Do, et al.
Journal of Oncology Practice|April 14, 2016
Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m2/minAndrea Cercek, Vivian Park, Rona Yaeger, et al.
Clinical Colorectal Cancer|March 19, 2025
A Phase Two, Single-Arm, Open-Label Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)Andrea Cercek, Jean-Baptiste Bachet, Jaume Capdevila, et al.
Cancer Cell|November 1, 2024
Fertility outcomes post immune checkpoint inhibitor exposureEmily C Harrold, Martinique Ogle, Erin O'Brien, et al.
Clinical Colorectal Cancer|February 7, 2022
Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin HypersensitivitySalvador Alonso Martinez, Neil H Segal, Andrea Cercek, et al.
Current Treatment Options in Oncology|June 14, 2017
A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal MetastasesAndrea Cercek, Vyacheslav Gendel, Salma Jabbour, et al.
Pageof 22